Cat.#: ACPP-1196
| Despition | Insulin Receptor beta Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1584 | Human Human Leptin Protein (AC1584) | 100 µg | inquiry |
| ACPP-1223 | PAX8 Blocking Peptide (AC1223) | 250 µg | inquiry |
| ACPP-1480 | Human FKBP1B Protein (AC1480) | 5 µg | inquiry |
| ACPP-1426 | Human ENO2 Protein (AC1426) | 5 µg | inquiry |
| ACPP-1380 | Human LECT2 Protein (AC1380) | 2 µg | inquiry |
| ACPP-1162 | Recombinant Human GDNF Protein (Fc Tag) (AC1162) | 50 µg | inquiry |
| ACPP-1272 | Bestrophin Blocking Peptide (AC1272) | 250 µg | inquiry |
| ACPP-1593 | Human MED7 Protein (AC1593) | 5 µg | inquiry |
| ACPP-1523 | RPE65 Blocking Peptide (AC1523) | 250 µg | inquiry |
| ACPP-1553 | Human NRG4 Protein (AC1553) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.